Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

BACKGROUND: Anti–tumour necrosis factor (TNF) agents are effective in treating people with rheumatoid arthritis (RA), but are associated with (dose‐dependent) adverse effects and high costs. To prevent overtreatment, several trials have assessed the effectiveness of down‐titration compared with cont...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Verhoef, Lise M, van den Bemt, Bart JF, van der Maas, Aatke, Vriezekolk, Johanna E, Hulscher, Marlies E, van den Hoogen, Frank HJ, Jacobs, Wilco CH, van Herwaarden, Noortje, den Broeder, Alfons A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2019
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534285/
https://ncbi.nlm.nih.gov/pubmed/31125448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010455.pub3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak